Literature DB >> 23271775

Factors influencing patients' acceptance and adherence to active surveillance.

David F Penson1.   

Abstract

Clinical decision making in localized prostate cancer is a complicated, multidimensional process in which men often consider their own personal preferences, the advice of their healthcare providers, the opinions of their family and friends, and outside information sources. They synthesize all of this within the framework of their own unique socioeconomic situation, their social support network, and their preconceived impressions of their health and the health-care system. This is particularly germane when considering factors that influence a patient's acceptance of and adherence to active surveillance (AS). We propose a conceptual framework based on a previously described systematic-heuristic theoretical model of decision making in this setting. We identify a number of factors that patients systematically prioritize when considering AS. These include desire for cancer control or cure, age at diagnosis, and concern regarding side effects of treatment. The way patients value these factors and effectively decide on treatment is influenced by more heuristic factors, including physician recommendation, opinion of friends and family members, and overall decision uncertainty. These heuristic factors also play an important role in adherence when a patient elects AS. Finally, some of the factors, particularly the heuristic ones, are potentially modifiable and may serve as targets for future interventions to increase acceptance of and adherence to AS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271775      PMCID: PMC3540870          DOI: 10.1093/jncimonographs/lgs024

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  38 in total

1.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

2.  Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Authors:  Steven B Zeliadt; Scott D Ramsey; David F Penson; Ingrid J Hall; Donatus U Ekwueme; Leonard Stroud; Judith W Lee
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

3.  Factors that influence patient enrollment in active surveillance for low-risk prostate cancer.

Authors:  Michael A Gorin; Cynthia T Soloway; Ahmed Eldefrawy; Mark S Soloway
Journal:  Urology       Date:  2011-01-07       Impact factor: 2.649

4.  Quality of life, health outcomes, and identity for patients with prostate cancer in five different treatment groups.

Authors:  M E Galbraith; J M Ramirez; L W Pedro
Journal:  Oncol Nurs Forum       Date:  2001-04       Impact factor: 2.172

5.  Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.

Authors:  Scott D Ramsey; Steven B Zeliadt; Catherine R Fedorenko; David K Blough; Carol M Moinpour; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Megan E Fairweather; Ian M Thompson; Thomas E Keane; David F Penson
Journal:  World J Urol       Date:  2010-10-20       Impact factor: 4.226

6.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.

Authors:  Roderick C N van den Bergh; Ida J Korfage; Gerard J J M Borsboom; Ewout W Steyerberg; Marie-Louise Essink-Bot
Journal:  Qual Life Res       Date:  2009-08-09       Impact factor: 4.147

8.  Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.

Authors:  B Joyce Davison; John L Oliffe; Tom Pickles; Lawrence Mroz
Journal:  Oncol Nurs Forum       Date:  2009-01       Impact factor: 2.172

9.  Preferences of husbands and wives for outcomes of prostate cancer screening and treatment.

Authors:  Robert J Volk; Scott B Cantor; Alvah R Cass; Stephen J Spann; Susan C Weller; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

10.  Moderators of an uncertainty management intervention: for men with localized prostate cancer.

Authors:  Merle H Mishel; Barbara B Germino; Michael Belyea; Janet L Stewart; Donald E Bailey; James Mohler; Cary Robertson
Journal:  Nurs Res       Date:  2003 Mar-Apr       Impact factor: 2.381

View more
  17 in total

1.  In 2124, half of all men can count on developing prostate cancer.

Authors:  P A Pollock; A Ludgate; R J Wassersug
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

2.  Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Authors:  J S Blumenthal-Barby; Denise Lee; Robert J Volk
Journal:  CA Cancer J Clin       Date:  2015-05-21       Impact factor: 508.702

3.  Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program.

Authors:  Zackary D Berger; Jonathan C Yeh; H Ballentine Carter; Craig Evan Pollack
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.

Authors:  Heather Orom; D Lynn Homish; Gregory G Homish; Willie Underwood
Journal:  Urol Oncol       Date:  2013-12-12       Impact factor: 3.498

5.  Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.

Authors:  Richard M Hoffman; Tania Lobo; Stephen K Van Den Eeden; Kimberly M Davis; George Luta; Amethyst D Leimpeter; David Aaronson; David F Penson; Kathryn Taylor
Journal:  Med Decis Making       Date:  2019-10-21       Impact factor: 2.583

6.  A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.

Authors:  Behfar Ehdaie; Melissa Assel; Nicole Benfante; Deepak Malhotra; Andrew Vickers
Journal:  Eur Urol       Date:  2017-01-24       Impact factor: 20.096

7.  The effect of urologist experience on choosing active surveillance for prostate cancer.

Authors:  William G Chu; Brian J Kim; Jeff Slezak; Teresa N Harrison; Joy Gelfond; Steven J Jacobsen; Gary W Chien
Journal:  World J Urol       Date:  2015-03-12       Impact factor: 4.226

8.  Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.

Authors:  Yen-Chi L Le; Stephanie L McFall; Theresa L Byrd; Robert J Volk; Scott B Cantor; Deborah A Kuban; Patricia Dolan Mullen
Journal:  Narrat Inq Bioeth       Date:  2016

9.  Emotional Distress Increases the Likelihood of Undergoing Surgery among Men with Localized Prostate Cancer.

Authors:  Heather Orom; Willie Underwood; Caitlin Biddle
Journal:  J Urol       Date:  2016-08-06       Impact factor: 7.450

10.  Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.

Authors:  Yang Deng; Kunlin Xie; Christopher J Logothetis; Timothy C Thompson; Jeri Kim; Maosheng Huang; David W Chang; Jian Gu; Xifeng Wu; Yuanqing Ye
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.